EUVIMEDEUVIMED entdecken
Crossref

Diagnosis of pancreatic solid lesions by ultrasound endoscopy fine-needle biopsy with Franseen needles: macroscopic on-site (MOSE) versus rapid on-site (ROSE) evaluation. Is the pathologist necessary in the endoscopy suite?

E. Pijoan Comas, D. Vazquez Gomez, N. Zaragoza Velasco, A. L. Vargas García, M. Alburquerque Miranda, N. Torres Monclus, M. Figa Francesch, R. Ballester-Clau, M. Planella De Rubinat, F. González-Huix Lladó

Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S154

DOI: 10.1055/s-0044-1783026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von E. Pijoan Comas und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The evaluation of biopsy samples obtained with fine-needle biopsy (FNB-EUS) using Franseen needles by ultrasound endoscopy by endoscopist (Macroscopic On-Site Evaluation: MOSE) improves the diagnostic accuracy of pancreatic solid lesions. The achievement of macroscopic visible core (MVC)>4mm has a high diagnostic accuracy with MOSE.

Aim

To compare diagnostic accuracy of Rapid On-Site Evaluation (ROSE) and MOSE by endoscopist in pancreatic solid lesions.

Methods

Prospective bicentric study, consecutive recruitment of patients with pancreatic solid lesions in 2 general hospitals (MOSE was performed in hospital A and ROSE in hospital B). Franseen needles were used (Adquire, Boston Scientific). We evaluated: 1) diagnostic achievement and accuracy (including sensitivity, specificity, positive predictive value and negative predictive value) in solid pancreatic lesions; 2) MVC>4mm acquisition; and 3) number of needle passes needed with MOSE vs ROSE.

Results

A total of 132 patients were included (33 women, 68 men, median age 68,2±1,025). MOSE was performed in 90 (68.2%) and ROSE in 42 (31.8%); in 110 (83.3%) malign and 22 (16.7%) benign pancreatic solid lesions. Correct diagnosis by EUS-FNB was achieved in 89.4% patients (with MOSE 88.8%; and ROSE 92.9%; p=0.54). Sensitivity was 100%, specificity 89%, PPV 81.3% and NPV 100% (with MOSE: sensitivity 100%, specificity 87.5%, PPV 88.8% and NPV 100%; with ROSE: sensitivity 100%, specificity 92.1%, PPV 92.6% and NPV 100%). MVC>4mm was obtained in 72.7% (71.1% in MOSE, 76.2% in ROSE, p=0.67). There were no statistically significant differences in diagnosis achievement between MVC>4mm and

Zitieren

APA

Comas, E. P., Gomez, D. V., Velasco, N. Z., García, A. L. V., Miranda, M. A., Monclus, N. T., Francesch, M. F., Ballester-Clau, R., Rubinat, M. P. D., & Lladó, F. G. (2024). Diagnosis of pancreatic solid lesions by ultrasound endoscopy fine-needle biopsy with Franseen needles: macroscopic on-site (MOSE) versus rapid on-site (ROSE) evaluation. Is the pathologist necessary in the endoscopy suite?. Endoscopy, 56(S 02 S 02), S154. https://doi.org/10.1055/s-0044-1783026

Vancouver

Comas EP, Gomez DV, Velasco NZ, García ALV, Miranda MA, Monclus NT, et al. Diagnosis of pancreatic solid lesions by ultrasound endoscopy fine-needle biopsy with Franseen needles: macroscopic on-site (MOSE) versus rapid on-site (ROSE) evaluation. Is the pathologist necessary in the endoscopy suite?. Endoscopy. 2024;56(S 02 S 02):S154. doi:10.1055/s-0044-1783026

BibTeX
@article{Comas2024,
  author = {Comas, E. Pijoan and Gomez, D. Vazquez and Velasco, N. Zaragoza and García, A. L. Vargas and Miranda, M. Alburquerque and Monclus, N. Torres and Francesch, M. Figa and Ballester-Clau, R. and Rubinat, M. Planella De and Lladó, F. González-Huix},
  title = {Diagnosis of pancreatic solid lesions by ultrasound endoscopy fine-needle biopsy with Franseen needles: macroscopic on-site (MOSE) versus rapid on-site (ROSE) evaluation. Is the pathologist necessary in the endoscopy suite?},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {S 02 S 02},
  pages = {S154},
  doi = {10.1055/s-0044-1783026}
}
Kostenlos starten →